These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 27512688)

  • 1. Preclinical studies and prospective clinical applications for bacteria-targeted imaging: the future is bright.
    Heuker M; Gomes A; van Dijl JM; van Dam GM; Friedrich AW; Sinha B; van Oosten M
    Clin Transl Imaging; 2016; 4():253-264. PubMed ID: 27512688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted imaging of bacterial infections: advances, hurdles and hopes.
    van Oosten M; Hahn M; Crane LM; Pleijhuis RG; Francis KP; van Dijl JM; van Dam GM
    FEMS Microbiol Rev; 2015 Nov; 39(6):892-916. PubMed ID: 26109599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards clinical application of non-invasive imaging to detect bacterial infections.
    Ohlsen K; Hertlein T
    Virulence; 2018 Dec; 9(1):943-945. PubMed ID: 29417876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteria-targeted fluorescence imaging of extracted osteosynthesis devices for rapid visualization of fracture-related infections.
    López-Álvarez M; Heuker M; Sjollema KA; van Dam GM; van Dijl JM; IJpma FFA; van Oosten M
    Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2276-2289. PubMed ID: 35079847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical evaluation of 2-[
    Braams LM; Sijbesma JWA; Boersma HH; van Dijl JM; Elsinga PH; Glaudemans AWJM; Slart RHJA; van Oosten M
    Int J Med Microbiol; 2023 May; 313(3):151581. PubMed ID: 37209590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of Bacteria: Is there Any Hope for the Future Based on Past Experience?
    Ebenhan T; Lazzeri E; Gheysens O
    Curr Pharm Des; 2018; 24(7):772-786. PubMed ID: 29173155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future diagnostic agents.
    Gemmel F; Dumarey N; Welling M
    Semin Nucl Med; 2009 Jan; 39(1):11-26. PubMed ID: 19038597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small-molecule fluorescent probes: big future for specific bacterial labeling and infection detection.
    Wang Z; Xing B
    Chem Commun (Camb); 2021 Dec; 58(2):155-170. PubMed ID: 34882159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery.
    Righi E; Mutters NT; Guirao X; Del Toro MD; Eckmann C; Friedrich AW; Giannella M; Kluytmans J; Presterl E; Christaki E; Cross ELA; Visentin A; Sganga G; Tsioutis C; Tacconelli E
    Clin Microbiol Infect; 2023 Apr; 29(4):463-479. PubMed ID: 36566836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteria-Targeted Combined with Photothermal/NO Nanoparticles for the Treatment and Diagnosis of MRSA Infection In Vivo.
    Lv K; Li G; Pan X; Liu L; Chen Z; Zhang Y; Xu H; Ma D
    Adv Healthc Mater; 2023 Aug; 12(20):e2300247. PubMed ID: 37002944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial infection probes and imaging strategies in clinical nuclear medicine and preclinical molecular imaging.
    Sasser TA; Van Avermaete AE; White A; Chapman S; Johnson JR; Van Avermaete T; Gammon ST; Leevy WM
    Curr Top Med Chem; 2013; 13(4):479-87. PubMed ID: 23432010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards efficient immunotherapy for bacterial infection.
    McCulloch TR; Wells TJ; Souza-Fonseca-Guimaraes F
    Trends Microbiol; 2022 Feb; 30(2):158-169. PubMed ID: 34253452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing minority population of antibiotic-resistant bacteria.
    Huang T; Zheng Y; Yan Y; Yang L; Yao Y; Zheng J; Wu L; Wang X; Chen Y; Xing J; Yan X
    Biosens Bioelectron; 2016 Jun; 80():323-330. PubMed ID: 26852201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
    Medina E; Pieper DH
    Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whence Resistance?
    Guidry CA; Davies SW; Metzger R; Swenson BR; Sawyer RG
    Surg Infect (Larchmt); 2015 Dec; 16(6):716-20. PubMed ID: 26186101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteria-Responsive Nanoliposomes as Smart Sonotheranostics for Multidrug Resistant Bacterial Infections.
    Pang X; Xiao Q; Cheng Y; Ren E; Lian L; Zhang Y; Gao H; Wang X; Leung W; Chen X; Liu G; Xu C
    ACS Nano; 2019 Feb; 13(2):2427-2438. PubMed ID: 30657302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Status of SPECT Radiopharmaceuticals for Specific Bacteria Imaging.
    Signore A; Bentivoglio V; Varani M; Lauri C
    Semin Nucl Med; 2023 Mar; 53(2):142-151. PubMed ID: 36609002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.